1. Home
  2. MOLN vs BRCC Comparison

MOLN vs BRCC Comparison

Compare MOLN & BRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • BRCC
  • Stock Information
  • Founded
  • MOLN 2004
  • BRCC 2014
  • Country
  • MOLN Switzerland
  • BRCC United States
  • Employees
  • MOLN N/A
  • BRCC N/A
  • Industry
  • MOLN
  • BRCC Beverages (Production/Distribution)
  • Sector
  • MOLN
  • BRCC Consumer Staples
  • Exchange
  • MOLN Nasdaq
  • BRCC Nasdaq
  • Market Cap
  • MOLN 195.4M
  • BRCC 232.6M
  • IPO Year
  • MOLN 2021
  • BRCC N/A
  • Fundamental
  • Price
  • MOLN $5.56
  • BRCC $2.98
  • Analyst Decision
  • MOLN
  • BRCC Buy
  • Analyst Count
  • MOLN 0
  • BRCC 6
  • Target Price
  • MOLN N/A
  • BRCC $6.15
  • AVG Volume (30 Days)
  • MOLN 7.1K
  • BRCC 818.7K
  • Earning Date
  • MOLN 03-13-2025
  • BRCC 03-05-2025
  • Dividend Yield
  • MOLN N/A
  • BRCC N/A
  • EPS Growth
  • MOLN N/A
  • BRCC N/A
  • EPS
  • MOLN N/A
  • BRCC N/A
  • Revenue
  • MOLN $7,105,397.00
  • BRCC $405,262,000.00
  • Revenue This Year
  • MOLN N/A
  • BRCC $1.02
  • Revenue Next Year
  • MOLN $29.41
  • BRCC $9.38
  • P/E Ratio
  • MOLN N/A
  • BRCC N/A
  • Revenue Growth
  • MOLN N/A
  • BRCC 9.65
  • 52 Week Low
  • MOLN $3.32
  • BRCC $2.78
  • 52 Week High
  • MOLN $12.70
  • BRCC $7.14
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 53.39
  • BRCC 45.90
  • Support Level
  • MOLN $4.98
  • BRCC $2.91
  • Resistance Level
  • MOLN $5.91
  • BRCC $3.30
  • Average True Range (ATR)
  • MOLN 0.27
  • BRCC 0.17
  • MACD
  • MOLN 0.08
  • BRCC -0.01
  • Stochastic Oscillator
  • MOLN 69.45
  • BRCC 17.24

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About BRCC BRC Inc.

BRC Inc is a veteran-controlled company that serves premium coffee, content, and merchandise to active military, veterans, and first responders. it is committed to producing great coffee that consumers love, and high-quality merchandise that enables its community to showcase its brand. its omnichannel distribution has three components: Direct to Consumer channel includes its e-commerce business, through which consumers order products online and products are shipped to them, Its wholesale channel includes products sold to an intermediary such as convenience, grocery, drug, and mass merchandise stores, who in turn sell those products to consumers, and Outpost channel includes revenue from its Company-operated and franchised Black Rifle Coffee retail coffee shop locations.

Share on Social Networks: